146 related articles for article (PubMed ID: 35832243)
1. Application Value Analysis of Seven-Autoantibody Panel in the Lung Cancer Screening in Yunnan.
Li W; Sun Y; Xu N
Comput Intell Neurosci; 2022; 2022():2368155. PubMed ID: 35832243
[TBL] [Abstract][Full Text] [Related]
2. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
Ren Z; Ding HM; Qian X; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
[No Abstract] [Full Text] [Related]
3. The role of autoantibody detection in the diagnosis and staging of lung cancer.
Wang Y; Jiao Y; Ding CM; Sun WZ
Ann Transl Med; 2021 Nov; 9(22):1673. PubMed ID: 34988182
[TBL] [Abstract][Full Text] [Related]
4. Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer.
Chen P; Lu W; Chen T
J Clin Lab Anal; 2021 Nov; 35(11):e24020. PubMed ID: 34555232
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of autoantibodies combined with tumor markers in the detection of lung cancer.
Mu Y; Li J; Xie F; Xu L; Xu G
J Clin Lab Anal; 2022 Aug; 36(8):e24504. PubMed ID: 35596744
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer.
Mu Y; Xie F; Sun T
J Clin Lab Anal; 2020 Aug; 34(8):e23349. PubMed ID: 32372513
[TBL] [Abstract][Full Text] [Related]
7. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer.
Ma H; Wu T; Zhang Q; Ding Q
BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic efficiency of seven autoantibodies in lung cancer.
Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L
Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules.
Hu K; Gao L; Zhang R; Lu M; Zhou D; Xie S; Fan X; Zhu M
Heliyon; 2024 May; 10(9):e30576. PubMed ID: 38765082
[TBL] [Abstract][Full Text] [Related]
10. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL
PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095
[TBL] [Abstract][Full Text] [Related]
11. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
[TBL] [Abstract][Full Text] [Related]
12. The role of seven autoantibodies in lung cancer diagnosis.
Luo B; Mao G; Ma H; Chen S
J Thorac Dis; 2021 Jun; 13(6):3660-3668. PubMed ID: 34277058
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms].
Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573
[No Abstract] [Full Text] [Related]
14. [Early diagnosis of subtype in early clinical stage lung adenocarcinoma by using an autoantibody panel and computed tomography].
Meng QC; Gao PR; Ren PF; Song YP; Li HL
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):204-208. PubMed ID: 30669764
[No Abstract] [Full Text] [Related]
15. An analysis of the influencing factors of false negative autoantibodies in patients with non-small cell lung cancer.
Wang A; Hao Y; Huo Y; Xu X; Zhang Y
Front Oncol; 2024; 14():1358387. PubMed ID: 38800369
[TBL] [Abstract][Full Text] [Related]
16. Five tumor-associated autoantibodies expression levels in serum predict lung cancer and associate with poor outcome.
Li S; Ma Y; Xiong Y; Zhang P; Wang X; Wang Y; Yang Y
Transl Cancer Res; 2019 Aug; 8(4):1364-1373. PubMed ID: 35116879
[TBL] [Abstract][Full Text] [Related]
17. Clinical validation of an autoantibody test for lung cancer.
Boyle P; Chapman CJ; Holdenrieder S; Murray A; Robertson C; Wood WC; Maddison P; Healey G; Fairley GH; Barnes AC; Robertson JF
Ann Oncol; 2011 Feb; 22(2):383-9. PubMed ID: 20675559
[TBL] [Abstract][Full Text] [Related]
18. EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays.
Chapman CJ; Healey GF; Murray A; Boyle P; Robertson C; Peek LJ; Allen J; Thorpe AJ; Hamilton-Fairley G; Parsy-Kowalska CB; MacDonald IK; Jewell W; Maddison P; Robertson JF
Tumour Biol; 2012 Oct; 33(5):1319-26. PubMed ID: 22492236
[TBL] [Abstract][Full Text] [Related]
19. Early detection of lung cancer by using an autoantibody panel in Chinese population.
Ren S; Zhang S; Jiang T; He Y; Ma Z; Cai H; Xu X; Li Y; Cai W; Zhou J; Liu X; Hu X; Zhang J; Yu H; Zhou C; Hirsch FR
Oncoimmunology; 2018; 7(2):e1384108. PubMed ID: 29308305
[TBL] [Abstract][Full Text] [Related]
20. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.
Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
